NCT01510574View on ClinicalTrials.gov

A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)

NACompletedINTERVENTIONAL
Enrollment

749

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Misoprostol

3 x 200mcg tablets of oral misoprostol

DRUG

placebo

3 x placebo tablets resembling misoprostol taken orally

Trial Locations (4)

Unknown

Busiu Health Centre, Mbale

Lwangoli Health Centre, Mbale

Mbale Regional Referral Hospital, Mbale

Siira Health Centre, Mbale

All Listed Sponsors
collaborator

University of Liverpool

OTHER

collaborator

Liverpool School of Tropical Medicine

OTHER

collaborator

Makerere University

OTHER

collaborator

Mbale Regional Referral Hospital

OTHER

lead

Gynuity Health Projects

OTHER

NCT01510574 - A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso) | Biotech Hunter | Biotech Hunter